×
About 1,870 results

ALLMedicine™ Tinea Pedis Center

Research & Reviews  139 results

The Effect of Propolis in Tinea Pedis Treatment: A Randomized Controlled Study
https://clinicaltrials.gov/ct2/show/NCT04789083

Dec 20th, 2021 - Study Identification: Randomised Controlled Trial Study Status: This will begin Sponsor/Collaborators: SBS Scientific Bio Solutions Inc. Oversight: Patients will be given foot care training. At the same time, a phone call will be provided by the r...

Epidemiology of rosacea in a population-based study of 161,269 German employees.
https://doi.org/10.1111/ijd.15989
International Journal of Dermatology; Hilbring C, Augustin M et. al.

Dec 14th, 2021 - Rosacea is a common chronic skin condition, but data on its epidemiology and related comorbidities are scarce. To analyze the prevalence and associated cutaneous comorbidities of rosacea in Germany. Voluntary dermatological full-body examinations ...

Autoeczematization: A Strange Id Reaction of the Skin.
https://doi.org/10.12788/cutis.0342
Cutis Bertoli MJ, Schwartz RA et. al.

Nov 27th, 2021 - Autoeczematization, or id reaction, is a disseminated eczematous reaction that occurs due to a release of antigen(s) after exposure to a primary stimulus, with the eczema spreading to a site distant from the original one. This seemingly perplexing...

Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis
https://clinicaltrials.gov/ct2/show/NCT00804193

Oct 27th, 2021 - The objectives of this study were to demonstrate comparable safety and efficacy of Ciclopirox Olamine Topical Suspension (Test Product) and Ciclopirox Topical Suspension 0.77% (Reference Product) in the treatment of subjects with tinea pedis, and ...

see more →

Drugs  543 results see all →

Clinicaltrials.gov  20 results

The Effect of Propolis in Tinea Pedis Treatment: A Randomized Controlled Study
https://clinicaltrials.gov/ct2/show/NCT04789083

Dec 20th, 2021 - Study Identification: Randomised Controlled Trial Study Status: This will begin Sponsor/Collaborators: SBS Scientific Bio Solutions Inc. Oversight: Patients will be given foot care training. At the same time, a phone call will be provided by the r...

Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis
https://clinicaltrials.gov/ct2/show/NCT00804193

Oct 27th, 2021 - The objectives of this study were to demonstrate comparable safety and efficacy of Ciclopirox Olamine Topical Suspension (Test Product) and Ciclopirox Topical Suspension 0.77% (Reference Product) in the treatment of subjects with tinea pedis, and ...

A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis
https://clinicaltrials.gov/ct2/show/NCT04315051

Jun 18th, 2021 - Double-Blind, Randomized, Placebo Controlled Trial of the Safety and Efficacy of DBI-001 Gel in Patients with Interdigital Tinea pedis (T. pedis). The primary objective is to observe the antimicrobial effect of a daily application of DBI-001Gel fo...

Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet
https://clinicaltrials.gov/ct2/show/NCT04265521

Feb 15th, 2021 - A prospective, open, post-market study that will enroll male and female subjects diagnosed with foot fungus and at least one of the following conditions: heel cracks, calluses and/or dry feet. The investigation will consist of approximately 48 sub...

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis
https://clinicaltrials.gov/ct2/show/NCT01891305

Aug 1st, 2018 - The purpose of this study is to determine if the novel oral agent VT-1161 is safe and effective in treating patients with moderate - severe tinea pedis (also referred to as athletes foot). VT-1161 has been designed to inhibit CYP51, an enzyme esse...

see more →

News  41 results

Scaly patches on hand and feet
https://www.mdedge.com/familymedicine/article/240601/dermatology/scaly-patches-hand-and-feet
MDedge Family Medicine;

May 26th, 2021 - A potassium hydroxide (KOH) mount of skin scrapings from the patient’s feet and hand confirmed a diagnosis of unilateral tinea manuum and bilateral tinea pedis—the so-called 2-foot, 1-hand syndrome. Additionally, nail clippings from the patient’s.

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.staging.medscape.com/viewarticle/935774

Aug 17th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.medscape.com/viewarticle/935774

Aug 17th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

Cellulitis pearls
https://www.mdedge.com/familymedicine/article/197766/dermatology/cellulitis-pearls/page/0/1?channel=234
MDedge Internal Medicine;

Mar 28th, 2019 - Concheiro and colleagues did a retrospective study of 122 cases of cellulitis and found tinea pedis in 33% of the cases. 6 Muller et al.

Tinea Incognito in an Urban Pediatric Population
https://www.mdedge.com/dermatology/article/178666/pediatrics/tinea-incognito-urban-pediatric-population
Thomas Stringer, MD, MS, Julia K. Gittler, MD et. al.

Nov 1st, 2018 - Tinea incognito (TI) describes a dermatophytosis with often atypical clinical features attributed to prior use of topical corticosteroids or other immunomodulating agents. Tinea incognito may lack the scale and elevated margin typical of cutaneous.

see more →

Patient Education  5 results see all →